Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jean-Claude Ollier"'
Autor:
Jean-Jacques Tuech, Jean-Claude Ollier, Patrick Pessaux, Nicolas Regenet, Jean-Pierre Arnaud, Mohamed Ziani
Publikováno v:
International Journal of Colorectal Disease. 19:569-573
This study reviewed the outcome of endoscopic transanal resection (ETAR) for the treatment of patients with villous rectal adenomas (VRA).This study included 28 consecutive patients who underwent ETAR for VRA between October 1992 and December 2000. A
Autor:
Jean-Claude Ollier, Olivier Schneegans, Alessio Imperiale, Marie-Noelle Roedlich, Edmond Rust, Cyrielle Boulanger
Publikováno v:
Clinical Nuclear Medicine. 37:e206-e208
An incidentaloma is a mass lesion incidentally found, of uncertain significance, and clinically inert. Although incidentaloma is commonly referred to designate an adrenal lesion, it can denote any incidental lesion of other organs. We describe the un
Autor:
Gilles Calais, Jean-Claude Ollier, Laurence Collette, Vincent Klein, Etienne Bardet, Jean-François Bosset, Suzana Stojanovic-Rundic, Christoph Glanzmann, Alexander Beny, Jean-Luc Van Laethem, Pierre Clavere, Dominique Marchal, Jordi Giralt, Michel Bolla, René-Jean Bensadoun, Philippe Maingon, Patrice Cellier, Laurent Mineur
Publikováno v:
Lancet Oncology
Lancet Oncology, Elsevier, 2014, 15 (2), pp.184-190. ⟨10.1016/S1470-2045(13)70599-0⟩
Lancet Oncology, Elsevier, 2014, 15 (2), pp.184-190. ⟨10.1016/S1470-2045(13)70599-0⟩
Summary Background EORTC trial 22921 examined the addition of preoperative or postoperative chemotherapy to preoperative radiotherapy in patients with rectal cancer. After a median follow-up of 5 years, chemotherapy—irrespective of timing—signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::120f419f6dd08004b0bc3fd9ccd00149
https://doi.org/10.5167/uzh-92617
https://doi.org/10.5167/uzh-92617
Autor:
Olivier Bouché, Jacob Wals, Olivier Grobost, Laurent Bedenne, Harry Bleiberg, Bernard Nordlinger, Liliana Baila, Jean-Claude Ollier, Philippe Lasser, Eric Van Cutsem, Jaques Wils, Jean-Pierre Arnaud, Thierry Conroy, Muriel Debois, Jean-François Seitz, Thierry Morin, Philippe Rougier, Jerome Lacourt, Rémy Mackiewickz, Jose Guimares dos Santos
Publikováno v:
The Lancet. Oncology. 6(7)
Summary Background Systemic adjuvant chemotherapy can improve overall survival and reduce the incidence of distant metastases for patients with advanced colon cancer. This study aimed to investigate whether regional chemotherapy (given by intraperito
Publikováno v:
Gastroenterologie clinique et biologique. 27(2)
Autor:
Bernard, Denis, Jean-Claude, Ollier
Publikováno v:
Gastroenterologie clinique et biologique. 26(4)
Autor:
Jean-François Bosset, Marc Gignoux, Jean-Pierre Triboulet, Emmanuel Tiret, Georges Mantion, Dominique Elias, Patrick Lozach, Jean-Claude Ollier, Jean-Jacques Pavy, Mariette Mercier, Tarek Sahmoud, Philippe Ségol, Jean-Bernard Flamant, Jean-Pierre Arnaud, Jean-Pierre Plachot, Anne-Marie Mandard, Gaelle Chaillard
Publikováno v:
The New England journal of medicine. 337(3)
We conducted a multicenter, randomized trial to compare preoperative chemoradiotherapy followed by surgery with surgery alone in patients with stage I and II squamous-cell cancer of the esophagus.The preoperative combined therapy consisted of two one
Autor:
Alain Daban, Jean-Claude Ollier, Etienne Bardet, Laurence Collette, Gilles Calais, Alexander Beny, J.F. Bosset, L. Radosevic-Jelic, Laurent Mineur, Philippe Maingon
Publikováno v:
Journal of Clinical Oncology. 23:3505-3505
3505 Background: This 2 x 2 factorial trial evaluates the addition of CT to preop RT and that of postop CT vs nil on overall survival (primary end-point) and progression-free survival (secondary end-point). Methods: Eligibility: age 10 cm: 6.6 %. T s
Autor:
Alain Daban, Jean-Luc Van Laethem, Jean Claude Ollier, Laurence Collette, Jean François Bosset, Etienne Bardet, Pascal Cellier, L. Radosevic-Jelic, Gilles Calais, Pierre Clavere, Jordi Giralt, Dominique Marchal, Vincent Klein, Alexander Beny, Laurent Mineur, Philippe Maingon, Michel Bolla
Publikováno v:
ResearcherID
3560 Background: This 2x2 factorial design clinical trial evaluated the addition of Fluorouracil-based chemotherapy (CT) to preop RT and the use of adjuvant CT in patients with resectable T3-T4 M0 rectal cancer. The 5-year results showed that adding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f413646e7bdade863e1b85ca4a79d5eb
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000335419601296&KeyUID=WOS:000335419601296
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000335419601296&KeyUID=WOS:000335419601296